Effective with date of service July 11, 2023, NC Medicaid covers efgartigimod alfa and hyaluronidase-qvfc injection
Topics Related to Bulletins
Effective July 15, 2023, NC Medicaid covers beremagene geperpavec-svdt biological suspension mixed with excipient gel for topical application
Effective with date of service July 31, 2023, NC Medicaid covers rezafungin for injection, for intravenous use (Rezzayo)
Effective with date of service June 27, 2023, NC Medicaid covers glofitamab-gxbm injection, for intravenous use (Columvi)
This bulletin replaces NC Medicaid COVID-19 Vaccine and Reimbursement Guidelines for 2023-2024
Effective with date of service June 14, 2023, NC Medicaid covers pegunigalsidase alfa-iwxj injection, for intravenous use (Elfabrio).
NC Medicaid will begin publishing the POS vaccine rate file in January of 2024
Effective with date of service Oct. 1, 2023, NC Medicaid covers cholera vaccine, live, oral suspension for oral administration (Vaxchora).
Effective with date of service Oct. 1, 2023, NC Medicaid covers yellow fever vaccine, for subcutaneous use (YF-Vax)
Effective with date of service Oct. 1, 2023, NC Medicaid covers typhoid vaccine live oral Ty21a (Vivotif)